CAP-1002: Completed Phase I/II enrollment

Capricor completed enrollment of 25 boys ages >=12 in the open-label, U.S. Phase I/II HOPE-Duchenne trial evaluating intracoronary infusions of CAP-1002 into each of the 3 left ventricle cardiac terri...